The ThinkCancer! Feasibility Study
The ThinkCancer! Intervention: Protocol for a Feasibility Study Incorporating a Randomised Pilot Trial With an Embedded Process and Economic Evaluation
1 other identifier
interventional
24
1 country
7
Brief Summary
Background Wales, like other UK countries, has relatively poor cancer outcomes. Late diagnosis and a slow referral process are major contributors. General practitioners (GPs) and other care providers working in primary care are often faced with patients presenting with a multitude of non-specific symptoms that could be cancer. Safety netting can be used to manage diagnostic uncertainty by ensuring patients with vague symptoms are appropriately monitored. The ThinkCancer! Workshop is an educational behaviour change intervention aimed at the whole general medical practice team, designed to improve primary care approaches to ensure timely diagnosis of cancer. The workshop will consist of teaching and awareness sessions, appointment of a Safety Netting Champion and the development of a bespoke Safety Netting Plan. This study aims to assess the feasibility of the ThinkCancer! Intervention for a future definitive randomised controlled trial, in terms of recruitment, randomisation, retention, acceptability, adherence and barriers to the intervention. Methods The ThinkCancer! study is a randomised, multisite feasibility trial, with an embedded process evaluation and economic evaluation. Twenty-three to 30 general medical practices will be recruited across Wales, randomised in a ratio of 2:1 of intervention versus control who will follow usual care. The workshop will be delivered by a GP educator, and will be adapted iteratively throughout the trial period. Baseline practice characteristics will be collected via questionnaire. We will also collect Primary Care Interval (PCI), Two Week Wait (2WW) referral rate, conversion rate and detection rate at baseline and six months post-randomisation. Participant feedback, researcher reflective notes and economic costings will be collected following each workshop. A process evaluation will assess implementation using an adapted Normalisation Measure Development (NoMAD) questionnaire and qualitative interviews. An economic feasibility analysis will inform a future economic evaluation. Discussion This study will allow us to test and further develop a novel evidenced-based complex intervention aimed at general practice teams to expedite the diagnosis of cancer in primary care. The results from this feasibility study will inform the future design of a full-scale definitive phase III trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Feb 2020
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2020
CompletedFirst Submitted
Initial submission to the registry
December 23, 2020
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedApril 1, 2021
March 1, 2021
1.5 years
December 23, 2020
March 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of a future definitive trial
Number of practices approached, interested in participating, consented and randomised, retention of recruited practices, ability to collect data
From date of initial expression of interest to participate to end of follow up period (13 months)
Secondary Outcomes (2)
Two Week Wait referral rate
Six months pre-randomisation and six months post-randomisation
Primary Care Interval
Six months pre-randomisation and six months post-randomisation
Study Arms (2)
Usual practice
NO INTERVENTIONUsual practice
Intervention
EXPERIMENTALReceives educational workshop
Interventions
The proposed intervention, the ThinkCancer! Workshop, is practice-based and consists of themed sessions for both clinical and non-clinical staff, the co-production of a Cancer Safety Netting Plan (CSNP) and the appointment of a Cancer Safety Netting Champion (CSNC). The workshop aims to raise awareness and increase knowledge around current cancer diagnosis guidance and will be delivered over half a day during GP protected time in the form of face-to-face educational sessions. Sessions will consist of a series of interactive activities exploring existing processes within practices and developing plans for change to implement each component.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bangor Universitylead
- Cancer Research Walescollaborator
- North Wales Organisation for Randomised Trials in Healthcollaborator
Study Sites (7)
Betsi Cadwaldr University Health Board
Bangor, United Kingdom
Aneurin Bevan University Health Board
Blaenau Gwent, United Kingdom
Hywel Dda University Health Board
Camarthenshire, United Kingdom
Cardiff and Vale University Health Board
Cardiff, United Kingdom
Cwm Taf Morgannwg University Health Board
Cwm Taf, United Kingdom
Powys Teaching Health Board
Powys, United Kingdom
Swansea Bay University Health Board
Swansea, United Kingdom
Related Publications (1)
Disbeschl S, Surgey A, Roberts JL, Hendry A, Lewis R, Goulden N, Hoare Z, Williams N, Anthony BF, Edwards RT, Law RJ, Hiscock J, Carson-Stevens A, Neal RD, Wilkinson C. Protocol for a feasibility study incorporating a randomised pilot trial with an embedded process evaluation and feasibility economic analysis of ThinkCancer!: a primary care intervention to expedite cancer diagnosis in Wales. Pilot Feasibility Stud. 2021 Apr 21;7(1):100. doi: 10.1186/s40814-021-00834-y.
PMID: 33883033DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Clare Wilkinson
Bangor University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2020
First Posted
April 1, 2021
Study Start
February 5, 2020
Primary Completion
August 1, 2021
Study Completion
August 1, 2021
Last Updated
April 1, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share